FOR IMMEDIATE RELEASE
PHILADELPHIA, PA – October 21st, 2019 – Miklos Schulz, CEO of SCiAN Services will be attending a two-day workshop on October 23 & 24 in Montreal to discuss the use of isoquercetin in the treatment of Ebola in the Democratic Republic of the Congo.
The workshop is hosted by the Montreal Clinical Research Institute and individuals invited from the government, academic and private sectors will convene to discuss new measures to treat and prevent the Ebola virus disease.
“The Ebola outbreak continues to be a global health crisis.” said Dr. Miklos Schulz, CEO. “I am honoured to be a member of the working group that will focus on developing protocols and ethics guidelines for this new treatment strategy.”
SCiAN Services is a leading contract research organization (CRO) providing customized clinical trial services for clinical-stage start-ups and mid-size biotechnology companies.
For clinical-stage start-ups, we set-up, manage and execute all study activities from trial design, regulatory filing, trial management, DSMB, safety/DSUR updates, pharmacovigilance, data management, biostatistics and medical writing.
For mid-size bio-pharma companies, we offer large-scale biostatistics, statistical programming and data management services with high quality standards, timelines and deliverables maintained throughout the trial.
With 30+ years of experience in IND stage clinical trials and 690 studies completed, SCiAN’s therapeutic area expertise includes immune-oncology, oncology, CNS, infectious diseases, inflammatory / autoimmune diseases and diabetes.
For more information, please contact:
2150 Islington Avenue,
Toronto, ON, M9P 3V4
Ph: 416 231 8008
3675 Market Street,
Philadelphia, PA 19104
2950 Buskirk Ave,
Walnut Creek, CA 94597